Our Team

Capital Markets:

• Pharmaron Beijing Co., Ltd. (3759.HK) in the approximately US$679 million dual primary listing and H shares offering in Hong Kong
• Brii Biosciences Limited (2137.HK) in the approximately US$358 million IPO and listing on the Hong Kong Stock Exchange
• Dexin China Holdings Company Limited (2019.HK) in the approximately US$216 million IPO and listing on the Hong Kong Stock Exchange
• CICC and Jefferies as joint sponsors and other underwriters in the spin-off of Sisram Medical Ltd (1696.HK) and the approximately US$128 million IPO and listing on the Hong Kong Stock Exchange (China Business Law Journal: China Deal of the Year 2017)
• BNP, CCB and ICBC and other underwriters in the spin-off of Central China Management Company Limited (9982.HK) and the approximately US$126 million IPO and listing on the Hong Kong Stock Exchange
• CCB as sole sponsor and other underwriters in the approximately US$83 million IPO and listing of Kangqiao Service Group Limited (2205.HK) on the Hong Kong Stock Exchange
• ABCI as sole sponsor, joint global coordinators including CICC and other underwriters in the IPO and listing of H shares of Lushang Life Services Co., Ltd. (2376.HK) on the Hong Kong Stock Exchange
• Haitong and CCB as joint sponsors and other underwriters in the IPO and listing of Huafang Group Inc. (3611.HK) on the Hong Kong Stock Exchange
• Eight Roads and F-Prime as pre-IPO investors in the IPO and listing of Sipai Health Technology Co., Ltd. (314.HK) on the Hong Kong Stock Exchange
• China VAST Industrial Urban Development Company Limited (6166.HK) in the offering of US$180 million Regulation S high-yield notes due 2021
• South Shore Holdings Limited (577.HK) in the US$200 million placement of new shares and/or convertible bond with an upsize option up to US$100 million
• China Industrial Securities in the approximately US$121 million top-up share placement and subscription for C&D International Investment Group Limited (1908.HK)
• CICC in the approximately US$104 million top-up share placement and subscription for C&D International Investment Group Limited (1908.HK)

Mergers and Acquisitions:

• China VAST Industrial Urban Development Company Limited (6166.HK) and its controlling shareholder, Profit East Limited, in the approximately US$285 million privatization by China Jinmao Holdings Group Limited (817.HK) by way of scheme of arrangement and delisting from the Hong Kong Stock Exchange
• Enice Holding Company Limited (ASX: ENC) and its controlling shareholders in the approximately US$14 million privatization by the controlling shareholders by way of scheme of arrangement and delisting from the Australian Stock Exchange
• Joy Bright Investments Limited and its affiliates in the approximately US$233 million acquisition of the entire equity interests in Tianjin China Minsheng Drawin Technology Limited, which held a controlling stake in DIT Group Limited (726.HK), triggering a mandatory general offer obligation under Hong Kong Takeovers Code, with the maximum consideration of the offer as approximately US$58 million
• Shenzhen Waranty Assets Management Company Limited and its affiliates in the approximately US$68.3 million acquisition of a controlling stake in Kontafarma China Holdings Limited (1312.HK), triggering a mandatory general offer obligation under Hong Kong Takeovers Code, with the maximum consideration of the offer as approximately US$30 million
• Joy Bright Investments Limited, the largest shareholder of Central China Real Estate Limited (832.HK), in the approximately US$363 million acquisition of the entire issued share capital of the company held by Singapore’s Temasek owned CapitaLand LF (Cayman) Holdings Co., Ltd., the second largest shareholder of the company
• Central China Real Estate Limited (832.HK) and its controlling shareholder in the sale of 29.01% stake in the company for approximately US$83 million
• Fosun International Limited (656.HK) in the approximately US$127 million acquisition of Clear Water Bay TV City Property
• SOCAM Development Limited (983.HK) in the approximately US$102 million sale of Four Seasons Hotel Pudong
• Bosideng International Holdings Limited (3998.HK) in the approximately US$99 million and approximately US$82 million acquisition of two PRC ladieswear companies respectively
• Lantronix Inc. (NASDAQ: LTRX) in the US$4.9 million acquisition of all of the business of Maestro & FALCOM Holdings Limited, a leader in wireless in the Internet of Things
• Jones Lang LaSalle Inc (NYSE: JLL) in the acquisition of several companies engaged in real estate and property management business
• WPP plc (LSE: WPP) in the acquisition of several companies engaged in media agency, public relations and communications business
• Maxim’s Caterers Limited in the acquisition of the franchise of COVA in Hong Kong and Macau
• Maxim’s Caterers Limited in forming a joint venture to operate under the franchise of MX cakes & bakery in Thailand

Compliance:

• RemeGen Co., Ltd. (9995.HK), Brii Biosciences Limited (2137.HK), Hua Medicine (2552.HK), Kangqiao Service Group Limited (2205.HK), DIT Group Limited (726.HK), China Tangshang Holdings Limited (674.HK) and Huarong International Financial Holdings Limited (993.HK) on their post-listing compliance and regulatory matters
• Huatai (Hong Kong) Futures Limited in application for SFC Type 2 and Type 5 licences

*including experience from previous firms.